Unilever’s (ULVR.L) strategy was under the investor microscope on Thursday after the consumer goods giant effectively abandoned its $68 billion pursuit of GlaxoSmithKline’s (GSK.L) consumer healthcare business. Shares in Unilever, …
@2024 – Chijosnews.com. All Rights Reserved.